Low platelet counts in cancer patients: Should heparin for venous thromboembolism prophylaxis be instituted? Reply

被引：0
|
作者：
Khorana, Alok A. [1 ]
Francis, Charles W. [2 ]
Falanga, Anna [3 ]
Lyman, Gary H. [4 ]
机构：
[1] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA
[2] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA
[3] United Hosp Bergamo, Dept Hematol Oncol, Bergamo, Italy
[4] Duke Univ, Dept Med, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 11期
关键词：
D O I：
10.1200/JCO.2008.16.0887
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1906 / 1907
页数：2
相关论文
共 50 条
  • [31] Low-molecular-weight Heparin (enoxaparin) versus unfractionated heparin for venous thromboembolism prophylaxis in patients undergoing craniotomy
    Kandula, Viswajit
    Shah, Parth, V
    Thirunavu, Vineeth M.
    Yerneni, Ketan
    Karras, Constantine
    Abecassis, Zachary A.
    Hopkins, Benjamin
    Bloch, Orin
    Potts, Matthew B.
    Jahromi, Babak S.
    Tate, Matthew C.
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 223
  • [32] Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma
    Jacobs, Benjamin N.
    Cain-Nielsen, Anne H.
    Jakubus, Jill L.
    Mikhail, Judy N.
    Fath, John J.
    Regenbogen, Scott E.
    Hemmila, Mark R.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2017, 83 (01): : 151 - 158
  • [33] Low-molecular-weight heparin versus unfractionated heparin for prophylaxis of venous thromboembolism in medicine patients: a pharmacoeconomic analysis
    Wilbur, Kerry
    Lynd, Larry
    Sadatsafavi, Mohsen
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 266 - 266
  • [34] Low molecular weight heparin for venous thromboembolism prophylaxis in urologic oncologic surgery
    Sawczuk, IS
    Williams, D
    Chang, DT
    CANCER INVESTIGATION, 2002, 20 (7-8) : 889 - 892
  • [35] Venous thromboembolism in a general hospital - An update with low molecular weight heparin prophylaxis
    Schulz, S. L.
    Kesselring, C.
    Seeberger, U.
    Andresen, D.
    VASA-JOURNAL OF VASCULAR DISEASES, 2007, 36 (01): : 17 - 22
  • [36] Initiation of rivaroxaban following low molecular weight heparin for venous thromboembolism prophylaxis
    Mills, R. M.
    Damaraju, C. R., V
    Jennings, L. K.
    Wildgoose, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 860 - 860
  • [37] Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients? Reply
    Meyer, G
    Farge, D
    ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (10) : 1244 - 1244
  • [38] A Retrospective Analysis of the Effectiveness of Low Molecular Weight Heparin for Venous Thromboembolism Prophylaxis in Trauma Patients Discussion
    Wilson, Slate
    AMERICAN JOURNAL OF SURGERY, 2014, 207 (05): : 651 - 652
  • [39] Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients
    Deusenberry, Christina M.
    Bardsley, Casey
    Sharon, Mindy
    Hobbs, Gerald R.
    Wilson, Alison M.
    Bardes, James M.
    AMERICAN SURGEON, 2023, 89 (12) : 5837 - 5841
  • [40] Prescription of low molecular weight heparin (LMWH) for prophylaxis against venous thromboembolism (VTE) in medical patients
    Wardle, J
    Webb, J
    Holmes, J
    Myers, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 7 - 7
12345